NCT01051557 2021-07-19Temsirolimus and Perifosine in Treating Patients With Recurrent or Progressive Malignant GliomaNational Cancer Institute (NCI)Phase 1/2 Completed36 enrolled 15 charts
NCT00590954 2020-10-19Clinical and Molecular-Metabolic Phase II Trial of Perifosine for Recurrent/Progressive Malignant GliomasMemorial Sloan Kettering Cancer CenterPhase 2 Completed32 enrolled 8 charts